Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Clinical Reasoning: Bacterial meningitis causing a neuromyelitis optica flare.
Epidemiology of Major Neurodegenerative Diseases in Women: Contribution of the Nurses' Health Study.
Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis.
Living with uncertainty and hope: A qualitative study exploring parents' experiences of living with childhood multiple sclerosis.
Webwise.
Modeling Chronic Traumatic Encephalopathy: The Way Forward for Future Discovery.
An Unanticipated Pattern of Sleep-Disordered Breathing in a Patient with Multiple Sclerosis.
Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: a 6-month randomized, double-blind, placebo-controlled study. Sulthiame Study Group.
Reversible disconnection syndrome in a case of acute tumefactive demyelinating lesion: a PET study.
Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis.
Disease modifying therapies for relapsing multiple sclerosis.
Addressing Concerns Regarding the Use of Gadolinium in a Standardized MRI Protocol for the Diagnosis and Follow-Up of Multiple Sclerosis.
Altered tumor growth factor beta mRNA expression is associated with thymectomy-related clinical remission in myasthenia gravis.
Presence of CpG DNA and the local cytokine milieu determine the efficacy of suppressive DNA vaccination in experimental autoimmune encephalomyelitis.
Characteristics of Children and Adolescents With Multiple Sclerosis.
Improving the quality of life and psychological well-being of recently diagnosed multiple sclerosis patients: preliminary evaluation of a group-based cognitive behavioral intervention.
McDonald Criteria 2010 and 2005 Compared: Persistence of High Oligoclonal Band Prevalence Despite Almost Doubled Diagnostic Sensitivity.
Multiple sclerosis and employment: Associations of psychological factors and work instability.
Immunomodulatory effects of glatiramer acetate as they relate to stage-specific immune dysregulation in multiple sclerosis.
Current trends in autoimmunity and the nervous system.
Immunomodulatory treatments and cognition in MS.
Electrophysiologic features of fibular neuropathy in childhood and adolescence.
Neurodegeneration in MS and NMO: The Eye and the Blood.
Zinc in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
An update on the causes, assessment and management of third division sensory trigeminal neuropathies.

Pages